Cargando…

Atezolizumab Induces Necroptosis and Contributes to Hepatotoxicity of Human Hepatocytes

Atezolizumab is an immune checkpoint inhibitor (ICI) targeting PD-L1 for treatment of solid malignancies. Immune checkpoints control the immune tolerance, and the adverse events such as hepatotoxicity induced by ICIs are often considered as an immune-related adverse event (irAE). However, PD-L1 is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Yukinori, Winarski, Katie L., Sajib, Md Sanaullah, Ju, Anna, Wu, Wen Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380327/
https://www.ncbi.nlm.nih.gov/pubmed/37511454
http://dx.doi.org/10.3390/ijms241411694

Ejemplares similares